Display Settings:

Format

Send to:

Choose Destination
    Emerg Infect Dis. 2004 Dec;10(12):2218-20.

    Protective effectiveness of hantavirus vaccine.

    Source

    National Cancer Center, Goyang, Republic of Korea. bachism@empal.com

    Abstract

    A case-control study in the Republic of Korea evaluated the protective effectiveness of the hantavirus vaccine. Point estimates showed increasing effectiveness with increasing numbers of doses received: 25% for one dose, 46% for two doses, and 75% for three doses. All 95% confidence intervals overlapped zero; therefore, the findings could be due to chance.

    PMID:
    15663866
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk